Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Milne

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Alzheimer'S Research & Therapy|February 2, 2020
We need to think about data governance for dementia research in a digital eraRichard Milne, Carol Brayne
Big Data & Society|February 15, 2023
Disruption and dislocation in post-COVID futures for digital healthRichard Milne, Alessia Costa
Sociology of Health & Illness|September 23, 2023
Detecting value(s): Digital biomarkers for Alzheimer's disease and the valuation of new diagnostic technologiesAlessia Costa, Richard Milne
The Lancet. Psychiatry|March 29, 2017
Expanding engagement with the ethical implications of changing definitions of Alzheimer's diseaseRichard Milne, Jason Karlawish
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body|August 16, 2022
Ethical Challenges Associated with Pathogen and Host Genetics in Infectious DiseaseRichard Milne, Christine Patch
Big Data & Society|February 23, 2023
Understanding 'passivity' in digital health through imaginaries and experiences of coronavirus disease 2019 contact tracing appsAlessia Costa, Richard Milne
Pharmacoeconomics|January 19, 2013
Comparing subsidized access to medicines across payer systemsMichael Wonder, Richard Milne
The New Zealand Medical Journal|December 7, 2011
Access to new medicines in New Zealand compared to AustraliaMichael Wonder, Richard Milne
The New Zealand Medical Journal|January 13, 2012
Response to PHARMAC on Access to new medicines in New Zealand compared to AustraliaRichard Milne, Michael Wonder
The Lancet. Healthy Longevity|September 13, 2022
Ethics, evidence, and the environment in dementia risk reduction - Authors' replySebastian Walsh, Richard Milne, Carol Brayne
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Alzheimer'S Research & Therapy|February 2, 2020
We need to think about data governance for dementia research in a digital eraRichard Milne, Carol Brayne
Big Data & Society|February 15, 2023
Disruption and dislocation in post-COVID futures for digital healthRichard Milne, Alessia Costa
Sociology of Health & Illness|September 23, 2023
Detecting value(s): Digital biomarkers for Alzheimer's disease and the valuation of new diagnostic technologiesAlessia Costa, Richard Milne
The Lancet. Psychiatry|March 29, 2017
Expanding engagement with the ethical implications of changing definitions of Alzheimer's diseaseRichard Milne, Jason Karlawish
The New Bioethics : a Multidisciplinary Journal of Biotechnology and the Body|August 16, 2022
Ethical Challenges Associated with Pathogen and Host Genetics in Infectious DiseaseRichard Milne, Christine Patch
Big Data & Society|February 23, 2023
Understanding 'passivity' in digital health through imaginaries and experiences of coronavirus disease 2019 contact tracing appsAlessia Costa, Richard Milne
Pharmacoeconomics|January 19, 2013
Comparing subsidized access to medicines across payer systemsMichael Wonder, Richard Milne
The New Zealand Medical Journal|December 7, 2011
Access to new medicines in New Zealand compared to AustraliaMichael Wonder, Richard Milne
The New Zealand Medical Journal|January 13, 2012
Response to PHARMAC on Access to new medicines in New Zealand compared to AustraliaRichard Milne, Michael Wonder
The Lancet. Healthy Longevity|September 13, 2022
Ethics, evidence, and the environment in dementia risk reduction - Authors' replySebastian Walsh, Richard Milne, Carol Brayne
Pageof 9